Author:
De Luca Giuseppe,Verdoia Monica,Suryapranata Harry
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials;De Luca;JAMA,2005
2. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials;De Luca;Eur Heart J,2009
3. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS);European Association for Percutaneous Cardiovascular Interventions;Eur Heart J,2010
4. Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis;Hansen;J Invasive Cardiol,2010
5. Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials;Navarese;Platelets,2011